Literature DB >> 26190734

Prevalence of blood-borne viruses among Iranian dentists: Results of a national survey.

Mohammad Sadegh Ahmad Akhoundi1, Nafiseh Momeni1, Mehdi Norouzi2, Leila Ghalichi3, Ahmad Reza Shamshiri4, Seyed Moayed Alavian5, Vahdat Poortahmasebi2, Seyed Mohammad Jazayeri6.   

Abstract

OBJECTIVES: Health care workers, including dentists, are at the front line for acquiring blood-borne virus infections. This study aimed to investigate the prevalence of hepatitis B, hepatitis C and human immunodeficiency viruses among Iranian dentists.
MATERIAL AND METHODS: The survey included 1628 dental health care workers who attended the 51st annual Congress of the Iranian Dental Association. Data on the risk of blood-borne virus transmission during health care and infection control practices were gathered from self-administered questionnaires. Sera were screened serologically by enzyme-linked immunosorbent assay (ELISA). The positive samples were examined by polymerase chain reaction (PRC) followed by direct sequencing.
RESULTS: Six (0.36%) and 81 (5.0%) were positive for hepatitis B surface antigen (HBsAg) and (anti-hepatitis B virus core antigen (anti-HBc), respectively. Only 1 (0.061%) was positive for anti-hepatitis C virus (anti-HCV). No case was positive for anti-human immunodeficiency virus (anti-HIV). One case was diagnosed as being occult hepatitis B virus (HBV) infection. One thousand five hundred thirty-five (94.3%) of participants had received at least 1 dose of HBV vaccine. One thousand three hundred fifty-nine (88.5%) contained hepatitis B surface antibody (anti-HBs) > 10 IU/ml, of whom 55 (4.0%) were anti-HBc positive, suggesting that they had been infected with HBV in the past. Anti-HBc positive cases had past histories of hepatitis, either their own or their spouses'. Individuals with inadequate anti-HBs levels (< 10 IU/ml) were significantly more prevalent among anti-HBc positive cases (p < 0.001).
CONCLUSIONS: The prevalence of blood-borne viruses among dental HCWs found in this study was lower than past reports from Iranian dentists and general population. The implementation of HBV vaccination together with improvement in infection control procedures has reduced the potential for risk infection among Iranian dentists. This work is available in Open Access model and licensed under a CC BY-NC 3.0 PL license.

Entities:  

Keywords:  HBV vaccine; blood-borne viruses; dentists; health care workers; infection control; occult hepatitis B infection

Mesh:

Substances:

Year:  2015        PMID: 26190734     DOI: 10.13075/ijomeh.1896.00324

Source DB:  PubMed          Journal:  Int J Occup Med Environ Health        ISSN: 1232-1087            Impact factor:   1.843


  3 in total

1.  Prevalence of hepatitis B, C, and HIV among patients attending a teaching dental hospital. A 7-year retrospective study from the United Arab Emirates.

Authors:  Suhail H Al-Amad
Journal:  Saudi Med J       Date:  2018-05       Impact factor: 1.484

2.  Prevalence of occupational infectious diseases among primary oral health care teams and prevention measures.

Authors:  Sheila Cristina Vargas; Caio Fernando de Oliveira; Jane Dagmar Pollo Renner; Suzane Beatriz Frantz Krug; Lia Possuelo
Journal:  Rev Bras Med Trab       Date:  2020-12-11

3.  Global prevalence of hepatitis B virus serological markers among healthcare workers: A systematic review and meta-analysis.

Authors:  Gadji Mahamat; Sebastien Kenmoe; Etheline W Akazong; Jean Thierry Ebogo-Belobo; Donatien Serge Mbaga; Arnol Bowo-Ngandji; Joseph Rodrigue Foe-Essomba; Marie Amougou-Atsama; Chavely Gwladys Monamele; Chris Andre Mbongue Mikangue; Ginette Irma Kame-Ngasse; Jeannette Nina Magoudjou-Pekam; Cromwel Zemnou-Tepap; Dowbiss Meta-Djomsi; Martin Maïdadi-Foudi; Sabine Aimee Touangnou-Chamda; Audrey Gaelle Daha-Tchoffo; Abdel Aziz Selly-Ngaloumo; Rachel Audrey Nayang-Mundo; Jacqueline Félicité Yéngué; Jean Bosco Taya-Fokou; Lorraine K M Fokou; Raoul Kenfack-Momo; Dimitri Tchami Ngongang; Efietngab Atembeh Noura; Hervé Raoul Tazokong; Cynthia Paola Demeni Emoh; Cyprien Kengne-Ndé; Jean Joel Bigna; Onana Boyomo; Richard Njouom
Journal:  World J Hepatol       Date:  2021-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.